Global Botulinum Toxin in Medical Cosmetology Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Botulinum Toxin in Medical Cosmetology Market Research Report 2024
Botulinum Toxin is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin also used commercially in medicine, cosmetics.
According to Mr Accuracy reports’s new survey, global Botulinum Toxin in Medical Cosmetology market is projected to reach US$ 11380 million in 2034, increasing from US$ 5946.9 million in 2024, with the CAGR of 8.2% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Botulinum Toxin in Medical Cosmetology market research.
Global key players of botulinum toxin in medical cosmetology include Allergan, Ipsen, Medytox, LIBP, etc. Global top five manufacturers hold a share over 93%. In terms of product, 100u is the largest segment, with a share over 34% And in terms of application, the largest application is cosmetic, with a share over 51%.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Botulinum Toxin in Medical Cosmetology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong
Segment by Type
50U
100U
Others
Medical
Cosmetic
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Botulinum Toxin in Medical Cosmetology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Botulinum Toxin in Medical Cosmetology market is projected to reach US$ 11380 million in 2034, increasing from US$ 5946.9 million in 2024, with the CAGR of 8.2% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Botulinum Toxin in Medical Cosmetology market research.
Global key players of botulinum toxin in medical cosmetology include Allergan, Ipsen, Medytox, LIBP, etc. Global top five manufacturers hold a share over 93%. In terms of product, 100u is the largest segment, with a share over 34% And in terms of application, the largest application is cosmetic, with a share over 51%.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Botulinum Toxin in Medical Cosmetology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong
Segment by Type
50U
100U
Others
Segment by Application
Medical
Cosmetic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Botulinum Toxin in Medical Cosmetology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source